SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 131 filers reported holding SAGENT PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,489,000 | +23.2% | 99,375 | 0.0% | 0.01% | +25.0% |
| Q1 2016 | $1,209,000 | -17.4% | 99,375 | +8.0% | 0.01% | -11.1% |
| Q4 2015 | $1,464,000 | +36.3% | 92,043 | +31.4% | 0.01% | +28.6% |
| Q3 2015 | $1,074,000 | -50.1% | 70,041 | -20.9% | 0.01% | -41.7% |
| Q2 2015 | $2,151,000 | +25.3% | 88,492 | +19.8% | 0.01% | +20.0% |
| Q1 2015 | $1,717,000 | +44.7% | 73,846 | +56.2% | 0.01% | +42.9% |
| Q4 2014 | $1,187,000 | -43.4% | 47,277 | -29.9% | 0.01% | -41.7% |
| Q3 2014 | $2,097,000 | +20.3% | 67,416 | 0.0% | 0.01% | +20.0% |
| Q2 2014 | $1,743,000 | +10.6% | 67,416 | 0.0% | 0.01% | +11.1% |
| Q1 2014 | $1,576,000 | -18.2% | 67,416 | -11.2% | 0.01% | -10.0% |
| Q4 2013 | $1,927,000 | – | 75,945 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 462,824 | $7,364,000 | 8.63% |
| HealthCor Management, L.P. | 1,750,000 | $27,843,000 | 1.69% |
| ACUTA CAPITAL PARTNERS, LLC | 144,667 | $2,302,000 | 1.10% |
| THB ASSET MANAGEMENT | 615,546 | $9,793,000 | 1.05% |
| Penn Capital Management Company, LLC | 1,399,205 | $22,261,000 | 0.98% |
| Tamarack Advisers, LP | 450,000 | $7,160,000 | 0.94% |
| Piermont Capital Management Inc. | 139,020 | $2,212,000 | 0.70% |
| JW Asset Management, LLC | 101,630 | $1,617,000 | 0.60% |
| SECTORAL ASSET MANAGEMENT INC | 810,362 | $12,893,000 | 0.55% |
| Glacier Peak Capital LLC | 50,000 | $796,000 | 0.51% |